Toronto Dominion Bank
RNAM

Toronto Dominion Bank’s Avidity Biosciences RNAM Stock Holding History

Toronto Dominion Bank’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75,000
Closed -$5.41M – 2366
2025
Q4 		$5.41M Buy
+75,000
New +$4.84M 0.01% 829
2025
Q3 		– Sell
-3,532,825
Closed -$100M – 2072
2025
Q2 		$100M Buy
+3,532,825
New +$105M 0.17% 120

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Toronto Dominion Bank's RNAM Position: Q1 2026 in Review

Toronto Dominion Bank sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 75,000 shares — an estimated $5.41M sold.

Toronto Dominion Bank first reported a position in RNAM in Q2 2025 and held it in 2 quarters. The position peaked at $100M in Q2 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Toronto Dominion Bank reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 75,000 Avidity Biosciences shares in Q1 2026, an estimated $5.41M.
  • Toronto Dominion Bank first reported a position in Avidity Biosciences in Q2 2025 and held it in 2 quarters.
  • Toronto Dominion Bank's Avidity Biosciences position peaked at $100M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.